CMS’ GLP-1 Bridge Demonstration

Дата публикации: 24-06-2026 00:00:00

This Viewpoint discusses the US Centers for Medicare & Medicaid Services’ (CMS) extension of the Medicare Glucagon-Like Peptide-1 (GLP-1) Bridge and outlines unanswered questions related to how the bridge will affect Medicare.

Схожие новости

#	Наименование новости	Тональность	Информативность	Дата публикации
1	7 things to know about Medicare's new GLP-1 coverage	0	7	02-07-2026
2	Medicare is now covering some GLP-1 weight loss drugs for $50. Here’s what to know	5	7	01-07-2026
3	GLP-1 insurance change impacts millions of Americans: What to know, how to tell if you're covered	0	7	19-07-2026
4	GLP-1 drugs could reduce long-term sick leave: Study	0	18.9	26-07-2026
5	GLP-1 drugs could reduce long-term sick leave: Study	0	18.9	26-07-2026
6	Bridging the Information Gap: How Organizations Can Assess and Use Benefits Screeners	0	5	01-07-2026
7	Ohio study finds GLP-1s are reshaping restaurant habits, with users spending less	0	5.45	24-07-2026
8	В России создали гибкий "пластырь" для определения уровня глюкозы через пот	0	9.07	27-07-2026
9	New Medicaid Work Requirements May Strip Farmworkers of Health Insurance	-2	6	10-07-2026

Классификация: Пресс-релизы. Схожих патентов: 0. Схожих новостей: 9. Тональность: 0. Информативность: 8.21. Источник: www.jamanetwork.com.